Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Clinical trial NCT00866775 · COMPLETED
Trial details
- NCT number
- NCT00866775
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2013-05-01
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.